Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response

Owens, 2003, Alternatives routes of insulin delivery, Diabetes, 20, 886, 10.1046/j.1464-5491.2003.01076.x

Delie, 2005, Polymeric particulates to improve oral bioavailability of peptide drugs, Molecules, 10, 65, 10.3390/10010065

Brange, 1987

Morishita, 1992, Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats, Int J Pharm, 78, 9, 10.1016/0378-5173(92)90349-7

Mesiha, 1994, Enhanced oral absorption of insulin from desolvated fatty‐acid sodium glycocholate emulsions, Int J Pharm, 111, 213, 10.1016/0378-5173(94)90343-3

Asada, 1995, Absorption characteristics of chemically modified‐insulin derivatives with various fatty acids in the small and large intestine, J Pharm Sci, 84, 682, 10.1002/jps.2600840604

Morishita, 2007, A novel approach using functional peptides for efficient intestinal absorption of insulin, J Control Release, 118, 177, 10.1016/j.jconrel.2006.12.022

Chalasani, 2007, A novel vitamin B12‐nanosphere conjugate carrier system for peroral delivery of insulin, J Control Release, 117, 421, 10.1016/j.jconrel.2006.12.003

Sajeesh, 2006, Cyclodextrin‐insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery, Int J Pharm, 325, 147, 10.1016/j.ijpharm.2006.06.019

Damgé, 1988, New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier, Diabetes, 37, 246, 10.2337/diab.37.2.246

Damgé, 1997, Poly(alkylcyanoacrylate) nanospheres for oral administration of insulin, J Pharm Sci, 86, 1403, 10.1021/js970124i

Morishita, 2006, Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats, J Control Release, 110, 587, 10.1016/j.jconrel.2005.10.029

Zhang, 2005, Investigation of lectin‐modified insulin liposomes as carriers for oral administration, Int J Pharm, 294, 247, 10.1016/j.ijpharm.2005.01.018

Saffran, 1997, Insulin and the gastrointestinal tract, J Control Release, 46, 89, 10.1016/S0168-3659(96)01578-7

Damgé, 2007, Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats, J Control Release, 117, 163, 10.1016/j.jconrel.2006.10.023

Raj, 2003, Oral insulin—A perspective, J Biomater Appl, 17, 183, 10.1177/0885328203017003567

Reis, 2006, Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particles, J Microencapsul, 23, 245, 10.1080/02652040500286086

Reis, 2007, Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity, Eur J Pharm Sci, 30, 392, 10.1016/j.ejps.2006.12.007

Huguet, 1994, Hemoglobin encapsulation in chitosan/calcium alginate beads, J Appl Polym Sci, 51, 1427, 10.1002/app.1994.070510810

Schipper, 1997, Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement, Pharm Res, 14, 923, 10.1023/A:1012160102740

Silva, 2007

Tobio, 2000, The role of PEG on the stability in digestive fluids and in vivo fate of PEG‐PLA nanoparticles following oral administration, Coll Surf B Biointerfaces, 18, 315, 10.1016/S0927-7765(99)00157-5

Tobío, 1998, Stealth PLA‐PEG nanoparticles as proteins carriers for nasal administration, Pharm Res, 15, 270, 10.1023/A:1011922819926

Vila, 2002, Design of biodegradable particles for protein delivery, J Control Release, 78, 15, 10.1016/S0168-3659(01)00486-2

Caliceti, 1999, Improvement of the physicochemical and biopharmaceutical properties of insulin by poly(ethyleneglycol) conjugation, STP Pharma Sci, 9, 107

Reis, 2007, Alginate microparticles as novel carrier for oral insulin delivery, Biotechnol Bioeng, 96, 977, 10.1002/bit.21164

Li, 2007, Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats, Int J Pharm, 329, 182, 10.1016/j.ijpharm.2006.08.040

Sarmento, 2007, Alginate/chitosan nanoparticles are effective for oral insulin delivery, Pharm Res, 24, 2198, 10.1007/s11095-007-9367-4

Prego, 2006, Chitosan‐PEG nanocapsules as new carriers for oral peptide delivery: Effect of chitosan pegylation degree, J Control Release, 111, 299, 10.1016/j.jconrel.2005.12.015

Hinds, 2002, Effects of PEG conjugation on insulin properties, Adv Drug Deliv Rev, 54, 505, 10.1016/S0169-409X(02)00025-X

Rieux, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach, J Control Release, 116, 1, 10.1016/j.jconrel.2006.08.013

Sahlin, 1997, Enhanced hydrogel adhesion by polymer interdiffusion: Use of linear poly(ethylene glycol) as an adhesion promoter, J Biomater Sci Polym Ed, 8, 421, 10.1163/156856297X00362

Smart, 2005, The basics and underlying mechanisms of mucoadhesion, Adv Drug Del Rev, 57, 1556, 10.1016/j.addr.2005.07.001

Lehr, 1992, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int J Pharm, 78, 43, 10.1016/0378-5173(92)90353-4

Jani, 1990, Nanoparticle uptake by rat gastrointestinal mucosa: Quantitation and particles size dependency, J Pharm Pharmacol, 42, 821, 10.1111/j.2042-7158.1990.tb07033.x

Eldridge, 1990, Controlled vaccine release in gut‐associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches, J Control Release, 11, 205, 10.1016/0168-3659(90)90133-E

Michel, 1991, The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats, J Pharm Pharmacol, 43, 1, 10.1111/j.2042-7158.1991.tb05437.x

Damgé, 2000, Ileal uptake of polyalkylcyanoacrylate nanocapsules in the rat, J Pharm Pharmacol, 52, 1049, 10.1211/0022357001774967

Bendayan, 1990, Morphocytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium, Diabetologia, 33, 197, 10.1007/BF00404796

Bendayan, 1994, Biochemical and morpho‐cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats: Comparison between the effectiveness of duodenal and colon mucosa, Diabetologia, 37, 119, 10.1007/s001250050081

Aprahamian, 1987, Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Bioll Cell, 61, 69, 10.1111/j.1768-322X.1987.tb00571.x

Lin, 2007, Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery, Biomacromolecules, 8, 146, 10.1021/bm0607776